HMTXF OTC
Hemostemix Inc
1W: -13.1%
1M: -20.9%
3M: +16.1%
YTD: -30.7%
1Y: -38.1%
3Y: -51.8%
5Y: -80.4%
$0.04
-0.00 (-0.08%)
Weekly Expected Move ±7.4%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+100.0% ▲
Operating Income
-$2M
+15.2% ▲
Net Income
-$3M
-4.6% ▼
EPS (Diluted)
$-0.03
+9.2% ▲
EBITDA
-$2M
+15.2% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $2K | $1K | $495 | $223 | $0 |
| Gross Profit | -$2K | -$1K | -$495 | -$223 | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $650K | $180K | $623K | $385K | $3K |
| SG&A Expenses | $7M | $6M | $4M | $2M | $2M |
| Operating Expenses | $7M | $7M | $3M | $2M | $2M |
| Operating Income | -$5M | -$7M | -$3M | -$2M | -$2M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $106K | $10K | $350K | $0 | $625K |
| Income Before Tax | -$8M | -$7M | -$5M | -$3M | -$3M |
| Tax Expense | $0 | -$256K | $487K | $0 | $0 |
| Net Income | -$8M | -$6M | -$5M | -$3M | -$3M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.24 | $-0.11 | $-0.07 | $-0.03 | $-0.03 |
| EBITDA | -$5M | -$3M | -$3M | -$2M | -$2M |
| Shares Outstanding | 32M | 57M | 70M | 82M | 95M |